This question has been answered by the relevant Government Department.
Lord Mendelsohn to ask Her Majesty's Government whether access to Evusheld will form part of their commitment to providing early access to (1) life-saving, and (2) cutting-edge, medicines through the Innovative Medicines Fund. HL733
Legend for business item text
† Item that is new or altered.
[I] Indicates that the member concerned has a relevant registered interest.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.